<DOC>
	<DOCNO>NCT00400075</DOCNO>
	<brief_summary>To assess efficacy systemic corticosteroid alone first-line treatment polyarteritis nodosa microscopic polyangiitis without poor-prognosis factor define five-factor score ( FFS=0 ) , compare efficacy safety azathioprine v pulse cyclophosphamide adjunctive immunosuppressive therapy treat failure relapse .</brief_summary>
	<brief_title>CHUSPAN PAN BP Treatment Polyarteritis Nodosa Microscopic Polyangiitis Without Poor-Prognosis Factors</brief_title>
	<detailed_description>All patient initially treat systemic corticosteroid alone : optional IV methylprednisolone pulse ( 15 mg/kg ) treatment start follow oral prednisone ( 1 mg/kg/day ) accord taper schedule . Treating physician allow treat minor relapse corticosteroid without refer patient randomization , long prednisone dose exceed 0.5 mg/kg 1 month . Patients prednisone dos could taper 20 mg , fail enter remission relapse randomize receive either 6 month oral azathioprine ( 2mg/kg/day ) 6 cyclophosphamide pulse ( 0.6g/m2 D1 , D15 , D30 every month )</detailed_description>
	<mesh_term>Systemic Vasculitis</mesh_term>
	<mesh_term>Microscopic Polyangiitis</mesh_term>
	<mesh_term>Polyarteritis Nodosa</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<criteria>Men woman newly diagnose polyarteritis nodosa microscopic polyangiitis ; absence poor prognostic factor define fivefactor score ( serum creatinine &gt; 140 μmol/l 1.58 mg/dl , proteinuria &gt; 1 g/day , severe gastrointestinal tract involvement , specific cardiomyopathy and/or central nervous system involvement ; write informed consent . Both gender eligible ; age ≥ 15 year . age &lt; 15 year , previously treat systemic vasculitis ; history cancer ; pregnant breastfeeding woman ; psychiatric disorder might compromise compliance therapy ; contraindication study drug ; ongoing therapeutic trial ; concomitant viral hepatitis B C human immunodeficiency virus ( HIV ) infection</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Polyarteritis</keyword>
	<keyword>Vasculitis</keyword>
	<keyword>Therapy</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Azathioprine</keyword>
</DOC>